This was a first-in-human study of the PET radiotracer 11C-LSN3172176 for the muscarinic acetylcholine receptor subtype M1. The objectives of the study were to determine the appropriate kinetic model to quantify binding of the tracer to M1 receptors, and the reliability of the chosen quantification method. Methods: Six healthy subjects completed the test-retest protocol, and 5 healthy subjects completed the baseline-scopolamine blocking protocol. Multiple modeling methods were applied to calculate total distribution volume (V T) and nondisplaceable binding potential (BP ND) in various brain regions. The reference region was selected from the blocking study. The occupancy plot was applied to compute receptor occupancy by scopolamine and nondisplaceable distribution volume. Results: Tracer uptake was highest in the striatum, followed by neocortical regions and white matter, and lowest in the cerebellum. Regional time-activity curves were fitted well by all models. The 2-tissue-compartment (2TC) model fits were good, but the 2TC parameters often could not be reliably estimated. Because V T correlated well between the 2TC and 1-tissue-compartment (1TC) models after exclusion of unreliable estimates, the 1TC model was chosen as the most appropriate. The cerebellum showed the lowest V T, consistent with preclinical studies showing little to no specific binding in the region. Further, cerebellar V T did not change between baseline and blocking scans, indicating that the cerebellum is a suitable reference region. The simplified reference tissue model (SRTM) slightly underestimated 1TC BP ND, and the simplified reference tissue model 2 (SRTM2) improved BP ND estimation. An 80-min scan was sufficient to quantify V T and BP ND The test-retest study showed excellent absolute test-retest variability for 1TC V T (≤5%) and BP ND (≤10%). In the baseline and blocking studies, occupancy values were lower in the striatum than in nonstriatal regions, as may be attributed to differences in regional acetylcholine concentrations. Conclusion: The 1TC and SRTM2 models are appropriate for quantitative analysis of 11C-LSN3172176 imaging data. 11C-LSN3172176 displayed excellent test-retest reproducibility and is a highly promising ligand to quantify M1 receptors in the human brain.
This was a first-in-human study of the PET radiotracer 11C-LSN3172176 for the muscarinic acetylcholine receptor subtype M1. The objectives of the study were to determine the appropriate kinetic model to quantify binding of the tracer to M1 receptors, and the reliability of the chosen quantification method. Methods: Six healthy subjects completed the test-retest protocol, and 5 healthy subjects completed the baseline-scopolamine blocking protocol. Multiple modeling methods were applied to calculate total distribution volume (V T) and nondisplaceable binding potential (BP ND) in various brain regions. The reference region was selected from the blocking study. The occupancy plot was applied to compute receptor occupancy by scopolamine and nondisplaceable distribution volume. Results: Tracer uptake was highest in the striatum, followed by neocortical regions and white matter, and lowest in the cerebellum. Regional time-activity curves were fitted well by all models. The 2-tissue-compartment (2TC) model fits were good, but the 2TC parameters often could not be reliably estimated. Because V T correlated well between the 2TC and 1-tissue-compartment (1TC) models after exclusion of unreliable estimates, the 1TC model was chosen as the most appropriate. The cerebellum showed the lowest V T, consistent with preclinical studies showing little to no specific binding in the region. Further, cerebellar V T did not change between baseline and blocking scans, indicating that the cerebellum is a suitable reference region. The simplified reference tissue model (SRTM) slightly underestimated 1TC BP ND, and the simplified reference tissue model 2 (SRTM2) improved BP ND estimation. An 80-min scan was sufficient to quantify V T and BP ND The test-retest study showed excellent absolute test-retest variability for 1TC V T (≤5%) and BP ND (≤10%). In the baseline and blocking studies, occupancy values were lower in the striatum than in nonstriatal regions, as may be attributed to differences in regional acetylcholine concentrations. Conclusion: The 1TC and SRTM2 models are appropriate for quantitative analysis of 11C-LSN3172176 imaging data. 11C-LSN3172176 displayed excellent test-retest reproducibility and is a highly promising ligand to quantify M1 receptors in the human brain.
Authors: Mohammadreza Shariatgorji; Anna Nilsson; Richard J A Goodwin; Patrik Källback; Nicoletta Schintu; Xiaoqun Zhang; Alan R Crossman; Erwan Bezard; Per Svenningsson; Per E Andren Journal: Neuron Date: 2014-11-06 Impact factor: 17.173
Authors: Mika Naganawa; Ming-Qiang Zheng; Shannan Henry; Nabeel Nabulsi; Shu-Fei Lin; Jim Ropchan; David Labaree; Soheila Najafzadeh; Michael Kapinos; Johannes Tauscher; Alexander Neumeister; Richard E Carson; Yiyun Huang Journal: J Nucl Med Date: 2015-01-15 Impact factor: 10.057
Authors: W Gordon Frankle; Yiyun Huang; Dah-Ren Hwang; Peter S Talbot; Mark Slifstein; Ronald Van Heertum; Anissa Abi-Dargham; Marc Laruelle Journal: J Nucl Med Date: 2004-04 Impact factor: 10.057
Authors: Vladimir Shalgunov; Aren van Waarde; Jan Booij; Martin C Michel; Rudi A J O Dierckx; Philip H Elsinga Journal: Med Res Rev Date: 2018-11-18 Impact factor: 12.944
Authors: Ross D Markello; Justine Y Hansen; Zhen-Qi Liu; Vincent Bazinet; Golia Shafiei; Laura E Suárez; Nadia Blostein; Jakob Seidlitz; Sylvain Baillet; Theodore D Satterthwaite; M Mallar Chakravarty; Armin Raznahan; Bratislav Misic Journal: Nat Methods Date: 2022-10-06 Impact factor: 47.990
Authors: Kelly Smart; Mika Naganawa; Stephen R Baldassarri; Nabeel Nabulsi; Jim Ropchan; Soheila Najafzadeh; Hong Gao; Antonio Navarro; Vanessa Barth; Irina Esterlis; Kelly P Cosgrove; Yiyun Huang; Richard E Carson; Ansel T Hillmer Journal: Cereb Cortex Date: 2021-05-10 Impact factor: 5.357
Authors: Marius Ozenil; Jonas Aronow; Marlon Millard; Thierry Langer; Wolfgang Wadsak; Marcus Hacker; Verena Pichler Journal: Pharmaceuticals (Basel) Date: 2021-06-02
Authors: Chao Zheng; Daniel Holden; Ming-Qiang Zheng; Richard Pracitto; Kyle C Wilcox; Marcel Lindemann; Zachary Felchner; Li Zhang; Jie Tong; Krista Fowles; Sjoerd J Finnema; Nabeel Nabulsi; Richard E Carson; Yiyun Huang; Zhengxin Cai Journal: Eur J Nucl Med Mol Imaging Date: 2021-11-11 Impact factor: 10.057
Authors: Justine Y Hansen; Golia Shafiei; Jacob W Vogel; Kelly Smart; Carrie E Bearden; Martine Hoogman; Barbara Franke; Daan van Rooij; Jan Buitelaar; Carrie R McDonald; Sanjay M Sisodiya; Lianne Schmaal; Dick J Veltman; Odile A van den Heuvel; Dan J Stein; Theo G M van Erp; Christopher R K Ching; Ole A Andreassen; Tomas Hajek; Nils Opel; Gemma Modinos; André Aleman; Ysbrand van der Werf; Neda Jahanshad; Sophia I Thomopoulos; Paul M Thompson; Richard E Carson; Alain Dagher; Bratislav Misic Journal: Nat Commun Date: 2022-08-10 Impact factor: 17.694
Authors: James C McPartland; Matthew D Lerner; Anjana Bhat; Tessa Clarkson; Allison Jack; Sheida Koohsari; David Matuskey; Goldie A McQuaid; Wan-Chun Su; Dominic A Trevisan Journal: J Autism Dev Disord Date: 2021-05-27